You are on page 1of 5

Comparative Evaluation of

Mixing Dynamics in USP


Apparatus 2 using Standard
USP Vessels and PEAK Vessels

Charles C. Collins and Renuka R. Nair


G1"fIdflflfe Scbool ofPblll7J1{lCclUiw/ Sdences,

Duquesne Uuivenity, PittslJlwgb, PA

ABSTRACT
Objective: To compflre dissolution 1C.I7I/tS for cOllllllcn-ial formulations in USP Apparatus 2 /Ising t:ollvcntio71({/ uSP vessels
(lnd PEAKl'M vesse/s. Methods: Disso/utio71 stllt/ies flsing C07J/mcrt:ially available disintegrating fablets of f1cctfl'llli110pbcn
and l1aproxcl1 sodiu'IJI were conducted in USP Apparatus 2
/lsillg usp /I"d PEAK'" vessels. The effict of)onl" diJjerent
RPMs (25, SO, 7S/lnd 100) find tl,,-ee dissolutiollllledifl
('Vflte>; J % 1ivem 80 fllld pbospb/lte bliJjel; pH 5.8 ""d 7.4

fin-

tlcetfllJlinopben fllId 11f1p1'OXCn sodi/l1ll, 1'cspectively) on tbe

mixing dynamics ;11 the two vessels were investigated. Botb


1l0mlCflcratetf find c1eaerated media were employed in tbe dissolution stut/ies. To confirm tbe differences i1/ wixing, ifll1lY,
is ollLy due to tbe formll tion of /I cone lit tbe bottom of tbe u.sI'
vessel, dissolution st'lldies 011 these tflbiets we1'e fllso pe1fo17JJet/
ill US!' Appflmtlls I . Results: Sigllijiwl/t diJjcrellceJ (P
<0.05) ,vere detected fOI up to 20 lIIil/lltes ill tbe Ie/e/lse of
l1f1prOXen sodium tflblets lit RPM 50,75 find 100 in 'I1ondeflerflted alld deael'flted pbospb/lte bliJjer Oi H 7.4). Howevel; no
Sigllificll1lt difference in mixi1lg lvas seell /It 25 RPM. Relellse

of tbe drug from llflprOXCn sot/ium lfIblets sbowed si!fmjlamt


differem:es (p<0.05) ill botb 1l0lltieaeHIted lind defle1'flteti lvflter
find I % Tween 80 witb PFA l{fM vessels showing greflter releflse.
!uteresti71gly, 110 signifiCflnt differe1lce Wfll' detected in tbe reiel/se
profiLe llsing usp Appllrllt'llS I indicflting tbfll tbe diff'ere1lf
mixillg pl'Ojile is ill fnct due to deposition of powder at the bottom of tbe uSP vessel. Acetfl7J/;llopben tflblets sb01ved differences
iUl/Iixing in the nvo vessels ollly lit RPM 25. There was no difference in th e mixing of IlCetflminopben ;n the USP Apparlltfls I
fit 25 RPM. No djffi:rel1cewfI:r detected ;n wllter and 1 % Tween
80 fit 25 RPM 0/"111 bigher RPMs of SO, 75 tllld J 00 ill pbosphate b,iJjer (P H 5.8). COllclusio))s: PE;/"~" vessels jbow
;mp""oved mixing when C01JlPfl1w/ to uSP vessels indicllted by 1111
;ncreflse in the rdeflse profile (lind fI deo'ease i" varillbility)
witb tbe PEAJ....'T'1 vessels. Tbis is due to the shllpe of tbe vessel
whicb belps to displ/lce /Illy cone effict /It tbe bottolll of tbe vessel.
It i:.; possible thllt tablets tbm 1IIfty fflil to 1IIeet USP d;l'sotlltion
o'iterifl do so beCffuse ofPOOl' pm1icle dispersion wbicb Cfln be
overcome by tbe lise of PEA f.;'TM vessels.

INTRODUCTION
of t he problems
associate d with us p
Apparatus 2 is the forma
tion of a cone of material at
the bottom of the dissolution
vessel. Dosage forms, es peciall y
o n es with dense excipie nts,
tend to form a cone at the bottom of the vessel giving rise to
an unstirred regio n of drug
ma terial. T his redu ces the su rface a rea of th e disso lvin g
material in co ntact with th e
dosage fOfm and consequently
affects t he di sso lution rate.
Cone form atio n co uld be a
probl e m predomina ntl y with
Apparatus 2, but ma y also hap.
pen in Apparatus I if the parti
c1es are released From th e wire
mesh ba sket. Ea rli er studi es
have established the inAuence
of the geometry of the dissolu

ne

tion vessel, es pecia ll y the base


curvature, on the flow of the
di sso luti o n med ia and th c
hyd rodynam ic mi xing. Vessels
with different bottom concavity
lead to chan ges in hyd rodynamic mi xing within the dissolution
media large cnough to cause a
significa nt change ill the dissoluti o n rate (3,4,5). Recently
VanKel introduced the PEAKTM
dissolution vessel. The dimensions of this vessel are similar to
the co n ve n t ion al uSP vesse l.
The major djFference is th,H this
vessel has a small inverted cone
at its base. L1 a study conducted
by Dr. Arnold Beckett et a i,
PEAKHt vessels were found to
provide higher dissoluti on rates
for calibrator tablets an d
NCDA #2 prednisone tablets (6).
[n addition, it was also observed

th'lt the presence of dissolved


air did not influence th e dissolution res ults in the PEAKTM
vessel due to effective displace
ment of the cone by the sllla ll
indent at the base of th e PEAKTM
vessel. The present study was
undertaken to determ.ine if this
vessel would inAu ence dissolution studi es on cO lllm erciall y
available tab lets. Since the difference in mixi ng between USP
and PEAKTM vessels is assumed
to be primaril y due to the poorly mixed cone at the bott0111 of
the USP vessel, it was hypoth esized th.t as the speed
increased, it wou ld help to displace the cone. This
wo uld subseque ntl y
reduce the difference
in mi xing and dissolution rate in the two

Dissolution TecimologieslMAY 1998

Comparative Evaluation of Mixing Dynamics ... cont.


Table I. Oissolillion datil of accillmino,)hcn disi nt egrl ting IMblet' in US,'
AppllntluS 1 al ,"p ri(lIl.'! 5li.-rinR s peeds. II'hos ph a lc Burrer. pll 5.81
J.lI'M

Ti",. ,min)

"A, Hrln ... d

(Me. . .l ~. I) . . . -(; )

"

'"

00.

...::.4".....

1581 I IJ

4474.l S4

JOIS!202

"
"
W

4618.t2&4

~5

~11tlI i 2.9.1

'"

~~ ~I

19

~6

2.44

9~6

'N4JJ
9~

12< 448

, 1 fK>

l~WIJ81

8187iO~

00

'nO?

Q497~ O~M

"

'nI8~OJ7

9713-,- 141

100 34 ", 0.44

IOO.D

84~J 11.9~

81.57 ~ 1.1'"

20

"

....

I 18

oi

0 ~8

00

%74 t 1.21

%911. 1.25

"

100.49 t 0.61

10041 -'-

96.28.t 0.61

9(,.21

00

9983! 0.47

'!'Jill 10.%

1.

O~~

0.77

Tilble II . Dissolution dala of nllprOlcn sodillm lablets in USI' Apparall.~ 2


III various llCirrln!:: spuds. I Phosphate Huffer pH 7.4
MI':\I

"

"

11m. , .. iD)

'00

." ... -"S.D.. . . .,

l'SP

n :AJ(I"

10.8.-10 21

9.58", 2.S

00

B)2! 7.5

)5.84 3.34

,."
"

SS 6 11.1.31

55.77.1. 4 46

728ItI O.97

11.1 1 I, D)

'",

..
"

"

% N..... H<1

IS.)) .l. 12.78

8J.4! ~ 4IH

92.18.l. 1061

9482 ... 5.98

19 12:t 8.)6

32.87 2.39

5UJi 15.06

727 1 .l. 2S4

74.611

97.89 1M

17.24

"
"
",

81U9.l. )49}

00

I/J227.62

US I

",
"
"

876629.22

101.27 ... 0611

28.lJ.i. 1.55

472JS.19

~.72 i

0.2 5

93) i 9.111
%(I4 t 69)

24 sa 10 5.38

65.29

4442 -'- 457


!.

2.00

10.1

88.52 10 2.22

8768 t 7.93

101.061. U4

vesse ls. ~lo c heck for consistency of


res ults, di ssoluti o n studi es werc
performcd in t hree di sso lu t ion
media. Also, since the difference in
mixing was related to th e slupe of
t he vesse l, it can be assumed that
no difference wo uld be sec n with
Apparatus 1. Dissolved gases ha ve
also been shown to affect t he dissolutio n rate in US P vesse ls, e ither
alte ring the Aow pattern in the dissolu tio n media or in some Clses the
boundary layer at the solid-l iquid
interface. Ln an attempt to in vestigate this effect, dissolution studi es
wcre perfo rm cd in no nd cae rated
and dcacr:1tcd med ia .

Dissolllrioll7i:dJllologieslNlAY 1998

METHODOLOGY
Dissolution studics on commerciall y available disintegrating tablets of acetamino ph en
and naproxen sodium were
co ndu cted in US P Apparatus 2
using US P a nd PEAKTM vesse ls.
Dissolu tio n was performed at
four different speeds: 25, 50, 75
and I 00 ~P,\I. Three dissolution
media [phosp hate buffer (p i I
5.8 and 7.4 for "cetaminophen
and naproxen sodium respectively), water, and 1% l\veen
80[ were used in t he study. Both
n ondeaerated and deacrated
media we re used to investigate
the influence of presence at air
on the dissolution profi le.
Deaer~ltion was ac hi eved by
so ni c<ltin g the di sso luti o n
medium for 20 minutes. The
temperature of t he dissolution
m edium was maintained at
37(0.05)C. Dissolution of
acetami nop h e n a nd naproxen
sodium tablets we re also condu cted in USI' Apparatus I at 50
RP ,\1 us ing phosphate buffer as
the disso lu tio n media with both
the vcsse ls. All a nal yses were
performed by UV spectrophotomctry. Thc detection wavele ngth var ied with the drug:
2B nl11 for acetam ino phe n and
332 nm for naproxen. St<l ndard
curves were lin ca r with r! values
;"0.999. Sig nifi ca nt differences
in perce nt dissolution we re car ried o ut usin g a two-tailed ttest performcd in A1icr050ft
Excel softwa re, Ver 5.0.

RESULTS AND
DISCUSSION
I. Effect of RI'M 011 tbe mix;ug
dYllo'lIIics ill the two vessels:
There was more than a twOfold increase in the di ssolutio n
rate of acetaminophen in the
PEAKTM vesse ls co mpared to the

USI' vesse l at 25 111',\\ crable I).


The difference was obse rved
throu gho ut t he sa mplin g period. Almost 100% of th e drug
was released at the end of 15
min in the PEAKTM vesse l compared to on ly 40 % release in
th e USI' vesse l. The pe rcentage
of drug released differed sign ificantly (p<0.05) during the initial 10 minutes in the two type
of vesse ls at 50 and 75 111',\\ with
the PEAK TM vesse l s howing a
faster rate of dissolution. As t he
dissolution proceeded t h ere
appeared to be no difference in
t he re lease profile between the
two vesse ls wit h all the drug
being released by tI,e end of 20
min . Similarl y, no difference in
disso l ut ion was observed
throughout the dissolution
period between t he two vesse ls
at 100 RPM. Jntensity of agitation affected the mix.ing in both
t he vesse ls but the effec t was
less pronounced in the IlEAKTM
vessel. At <1 11 stirrin g speeds,
100% of the drug was re leased
in 20 min in the PEAKTM vessel.
l-l Qwevcr, in the usp vesse l the
lower intensity of agitation at
25 RPi\\ released on ly about
45 % o f t h e drug during the
same time period. No sig nifi cant difference in the release
profilc of naproxen sodi um in
the two vessels was see n at 25
RP ,\I. App roxi m ate ly 95% of
the drug was re leased at th e end
of 30 min in both t he vessels
(Table II ). T h e difference
became a ppare nt with increasing 1l1',\1. At 50 RPM, on ly 19%
of t he drug was released in t he
usp vessel within the first 5 min
cOlllp3red to a 32% release in
t he PEAKTM vesse l. As ex pected,
the difference between t he two
vesse ls decreased as dissolution
proceeded. By the end of 20
minutes, in the PEAK nl vesse l

100% of the drug was released


compared to 75% release in the
us p vessels. In addition, there
appeared to be a greater variability in the dissolution datel
for the USP vesse l. T he va riaGil ity ranged from 8- 14% in the
USP vessel com pared to only
0.2-2 % in the PEAK "r\1 vessel.
Similar differences in the dissolution rate and variab ili ty
between the two vesse ls were
observed at 75 and 100 RPM.
During the disso lutio n process,
the acetaminophen tablets disintegrated into gn1l1uJes. At the
low stirring speed of 25 RPM,
t hese g r anul es sett led at the
bottom of both vesse ls which
led to slowe r mixing. The di fference between the two vessels
was due to the sllla ll indentation prese nt in the PEAK TM vesse l. As the sti rrin g speed was
in creased, the granules, being
li ght in i1 i:ltu rc, tended to disperse throughout the m ed ium
in both the vesse ls rather t han
settle at the base. H ence, no
difference in m.ixin g was seen at
the hj g h er rates of ag itatio n.
[-I owcve r, n ap roxen sodium
tab lets disintegrated in to sma ll
particles. These particles tended to form a com pa ct mass iJ1
both vessels. At 25 RPM, the
inte nsity of agitation was tOo
low and th e m ass of particl es
were too co mpa ct to be quickly
di splaced in either of the vesse ls. I-I e nce, no differe n ce in
mixin g was observed. l-Iowever,
as the st irrin g speed was
inc reased , it ten ded to di spla ce
t he co ne more effective ly in the
PEAKTM vessel by virtu e of th e
indent ,-I t the bottom o f the vessel. This, howeve r, was not t he
case with th e uSP vesse l, thereby lead in g to a greater dissoluti o n in the PEAKTM vesse ls. The
co mp ,-lct mass at the b<lse of the

us p vesse l also gave ri se


to g re,-1ter va riability as
evid ent by the sta ndard
deviations.

Table III. Dinolulion dala oracelaminophen dis inlegraling tablets in USP


Apparatus 2 using various dissolulion media ,
% Rrlra..,d _ 50 RPM
(M .... '" S. Il . n"'fi)

Time
(mill)

2. Effect of dissolutio"
1lledin:

Acetaminophen
disintegrating tablets
As seen in Table ill, a
slllali difference of abou t
4 % was seen in the first 5
111111
In the p erce nt
release
of
acetamin o ph en w hen the dissolution was performed
in phospha te buffer 1'1-1
5.8. Wh en th e dissolutio n media was rep la ced
by water this difference
in c reased to 10% wi th
t he PEAKTM vesse ls showin g hi g h er dissolution
rate. The hi gher solubil ity of acetaminophen in
T\veen 80 resulted in no
observed
differ e nce
be twee n the two vesse ls.

"
"
"

Wnler

"hmpbMlr bufftr Ip" 5.8)

1% T""fU 110

IISP

PEA ".....

US,

PEAK''''

US,

O'EAK'"

75.39'" 3.8J

81.87 '" 0.86

80. 15 '" 5.6J

91.4 :1:3. 15

9S.JS:I: 3.68

97.65:1: 1.16

93.01'" 1.18

"".91 '" 0.58

97.5 1 :1: 1.1 7

100.76 '" 1.5

1110.13 '" 1.7

98.31 :1: 1.14

97. 18 '" 0.37

97.33 '" 1.43

100.17:1:0.28

100.3" '" 0.44

l00.5!5

O.l~1I

Table IV. Dissolution dab. ornaprolen sodium lablels in USP


Apparatus 2 in various dissolulion media
'Y. It .. lul!l SO ItPl\1
(MUll S. Il . nc6)

Time

1% T .."t u 80

10

usr

1'f:AJ('"

usr

.... K""

usr

19.1l s 1.36

JU7 '" 1..1'

It.7'''B.t

rF..AK'''

4 9.''''~.5

n.72"' .18

"'5J "'I."

$1.5,)", 15.011

71 .7 1 *1.54

,Ut. 10.7

9l.7"'H

75.811 ....1

75.2"'2.56

l OU I.1

9<4..1' '''J.I.I

".5 .. .1.76

~r

15

74.68"' 17.14

97.19 1.'5

'l.II ~ . 4

10

1IIL~"

".n. US

101.'''2.0

14.'l

".""'h7

Table V. Dinolution data (or acetaminopbcn disintegrating tablets in USI)


Apparalu!> I and 2 using USI) aod PEAk.'T)I vessels.
IPhosphate Buffer pH 5.8J
% Rr ....I!l . SO RPM

Tim.

(MUD S.I) a =6)

(m in )

Naproxen
sodium tablets
Diffe re n ces in mi x in g
pro fil e were seen fo r a ll
dissolution media in t he
case o f na proxen sod ium
tablets
Cfa bl e
IV).
Approximately 50% of
the drug was re leased in the
PEAKI'M vesse l within the initial
5 minutes co mp a red to only
30 % re le<1se in th e USP vesse l
with water as th e dissolution
m ed ium. A sig nifi ca nt difference (1'<0.05) was o bserved for
the Tween 80 so luti o n only
durin g th e initi a l S minutes.
This is because the su rfa cta nt
redu ces th e interfacial te nsion
betwee n th e so lid co ne a nd the
surroundin g med ia in the US P
vessel a nd narrows th e differe nces in release rate between

,
"
"
"

"

Apptlnolu.2

"ppIOra lus I

Us.

'''K"'

US,

I'r.... "....

"".66 '" ".21

" 5.2'" /i.05

75 .19 :1: 3.U

8 1.87'" 0.86

78.39:1: 6.57

79.74 '" 5.61

93.01'" 1.18

94.91:1: 0.58

9!.H8 :1: 5.45

9ZA~ :I:

4.504

91.111 0.37

97.33'" U J

97.77 '" ".13

%.69 3.42

100.14:1: 0.44

100.55 '" 0.811

100.21., O.R

100.6H:I: 0.71

th e USP and PEAKTM vesse ls.


However, the difference is too
s mall to hav e <lny pra ctica l
impli cations.

3. Testing Devices
Apparatus 1 and Apparatus 2
\"'h e n pe rfo rmin g the dissolution of ace taminoph e n in Apparatu s 2 at 50 RPM, a sig nifi ca nt
difference (I' < 0.05) in mixing
was o bse rved in th e initial 10
minutes. H owever, in Appararus 1 there wa s no sig njfi cant
difference (L1ble V). L1 the case
DissollltionTeclmologiesllvlAY 1998

Comparative Evaluation of Mixing Dynamics ... cont.


Table VI. Diuolution data for naprostn sodium disintegra ting tablelS in USP
Appllrlliull 1 Ilod 2 using US P ud "[AI(T'" wmd.
IPhospha te Buffer plf 7.41
% N~Ieued
( 'h. .

Ti", ..

50 NPM

s.n., ....,

(_I.)

App .... I.., 1

,", ppars'". I

USP

f'F.... " .....

10.49,", l.6.J

1!!.99 cO. ]

"'"

PF.... "-

I '-II,", LJ6

J1.87 2..19

"

18.77'" 5.66

45.0 1 .t 6.95

5 1.53:i 1S-1Mi

72.7. :l1.5ot

"

60.811

60.72

74.611 17.14

97.119

"
"
'"

76-17" 9..!17

n ..I.H . IOJ

88..59 14.93

99.72:l: o.:S

89.3.t 9.'4

87.19.t !f.4'

93.3,* 9.83

98. 181. 7.26

% .... 9.7

'Hi."":l 6.9 1

oj

7.'1

U4

j,

of<

1.65

Table VI I. Dissolution dill. of a ctlillninophen disinlegrilling Iliblel!l in USP


Ap l)lIn lu~ 1 PJing US P a nd ...:AJ(I.. l"I!uels using nonde- crated
a nd duera led pho5 ph.te buffer (p ll 5.8).
Tim.

,,,,i,, )

N. I<.~

( "" ... " .i

15 KPlI1

,
"
"
"
"
,
"
"
"

..

1 )ft~"ltd

"'"""o.d-.....'...
1.44

S,II" """)

"F..... "....

1ka<,,'nI

~ ."A.5.~

\1.56

U.14 Il 4.18

'#!I.JIIl 4.48

\/7.10 " J.6

'Hi"" s l.'!

19.~ 1

JO. 15A.l.01

~5.80"'UI

1~U4 1l

5S.91

ok

44.'4

...........

61.1151l 7.19

SU8sl.'U

116.111 t 8.7J

55.51

3.M

7.l..l 1 '" 8.115

75..l\11l JM

15.12'" 5.11

lllAl ",0.16

U."" 1.11 ".111 J: 1.15

,...,.,. s 0.58

3'.~.t 1.~4

It

5.",

Noad.Ht"II,ed

5."

15.81 :l 1,13

5OII.PM

". IM s 0037

".ll'" 1.4J

1 00J~ '" O.~4

100.5.1 s 11.811

Tlble VIII. Diuol ulioo d i ll ,,( naprU f n sodi um ill US I' Apparalull using us r a nd
I.:A .........tllub u.,ing nond uc r. lw and deae r. ted Ilhosphlli t bufftr (pll 7.4).
~;.....""

_ 1M... _ S.D~-;'

Nc.ocItM,, ' nI
lICIlI~M

"
"
"

""

I.."

I~ .a~ ~.'4

I.5t

O...... ,nI

JUJ ' l..)9


n.7 1 ~ I.SoI

- N"........... onI. 1. ' J.99

".14.'"

51..SJ.t 15.11>

Q.1Mo.t

7U'.17.z.4
...59. IoU}

il.lZ.'.l1

97....

... 71 .... l5

96.(14 .. "9 '

7..... IZA5
9!.1J .....
'I6.IJ J. 4.SII

1UI.SJI
t.J.1. 7.6:

UH*4.Jl

oUAJ. 4..57

","~.l.H

~}

17.'J l.as

17.... '.1

1JU1.

ll..lIl. 1.10
101.17. 0.68

' 0 1.1 5 A. 4.85

.U5 .. 7.-"1

.w. '.aJ

I~

M.}. !.54

~II~ I

"
"
'"
"
' '''111'1>1

"
"

"

.. 7."

'.1Mi

If ..... O...

".15,. (.48
Jl.Jj .. 7.55

1...... 5.lS

I>!.lt.l 10.1

"'-67.

87.~

.. J.tJ

911.01* l. ..

6.!2

'1.01 ' . 5.1

".111"

47.LI.5.I'

oft.'} oJ.J1

III.!J .. l.ll

U1J. U16

10 1.116 ..

I.J~

Vl). Since the naproxen


sodium tablet disintegrates
into particl es, some o f the
particles fell through the
bas ket and settl ed at th e
bottom . This may account
for the s li g ht difference
observed during the initial
10 minutes. In Apparatus
1, any difference in mixing
co uld be due to t he mesh
size. Unlike Apparatus 2,
t he curvature of the dissolu tio n fla s k s hou ld have
minimal impact o n the
dissoluti o n rate since the
do sage form is placed
in side th e basket. Si nce
similar mi xin g profil es
were o bserved for Appa ranls 1 and dissimilar Illixjng
profiles were observed for
Apparauis 2 for the same
dosage forms and dissolution test parameters the
hypothesis that t he shape
of the vessel is a significant
co nt ributo r to the differences is confirmed. ~rhi s
again confi rms that the formatio n of a cone in the uSP
vesse l ca n resuJt in non-formulatio n related decrease
in dissolution rate.

".JJ Il .. I

0.711

of naproxe n sodi um tablets, for


Apparatus 2, a very large difference of 12-20% was d etected
between th e two vessels
t hrou gho ut the sa mpling peri od. H oweve r, with Apparatus 1,
no s ig nifi ca nt diffe re nce was
seen in t he two vessels (Tabl e
Dirso/lIlioI/7i!C/m%giesIMA Y 1998

4. ["fiuellce of N01ldellerIltiolllDeneration
There was a signjfic;ult differe nce (1'<0.05) in the
amount of acetaminophen
rel eased in the nondeaerated/deaer ated m edia in
both USP and PEAKTM vesse ls (Ta ble Vll ). T he
amou nt of dr ug released
was hi gher in the nondeaerared
media compared to the deaerated m ed ia in both the vessels.
There was also a significa nt difference in the re lease profile of
acetaminophen in the two vessels in nondeaeratcd med ia.

Ap proxi mate ly 60% of th e


drug was released in the nonc1eaenncd media using US P vessels at t he end of 20 mjnurcs
compared to 100% release with
t he PEAK TM vessels. A significant
difference (I' < 0.05) in the mi xing profile due to nondeaeracion was also observed at 50
RPM in t he two vessels. There
was no difference in the dissolution profile of naproxen sod illlll tablets in nondeaeratedl
deaerated media in either of th e
two vesse ls (1::1b le Vnf). For
the sa me hyd rodyn amic reasons
di sc ussed in section two
(a bove), dissolution rate differe nces for naproxen sod ium
were observed betwe e n th e
PEAKnl and USP vessels in 11011deaerated media at 50, 75 and
100 RPM (nble VUl).

CONCLUSIONS
The PEAKTM vessels eliminate
the formation of a cone of material s in Apparatus 2 ofte n
observed with certa in kinds of
dosage form s. T his was evident
from visua l observation of the
vessel during dissolution study
and also from the dissolution
resu lts. T h e PEAKnl vesse ls
showed a higher release rate
wi th both the co mm ercia ll y
ava ilab le disintegra tin g tablets
empl oyed in this snldy. Contrary to previous studies, the
results fro m th is study indicated
that stirring speed and the presence of air can influ ence the
amo unt of drug released in bodl
vessels. PEAKTM vessels, however,
provide an effect ive way to
improve the mixing hydrodynami cs in the dissolution vessel
and reduce the variabi lity typicall y observed for conventional
USP vessels.
SI'I: Referen ces .. .continue,! flext page

Solax Awards

Product Quality Researc. Initiative


Illds llliUal Meelinl
fir ...'" ,.".. PI.' ..

SO 'l',\X ,\(: ,,,lch ml"", ," lSl h

III' . . . a:t.r or Iclallifil: An ....

AI the 1M181 Meetnl: oI1he f'roPJcI Qualrty Researdllni\lalM:

""'m,"

(F'QRI). IIeId rlfU1l"y 10 j l. 1998, 10 Washngtoo. DC, G,:wdon AmI


(\(:tl,

Ph.D., MPS f>resi:lcrl\. rnd larry Augsoorj,'<X- Ph ,D.. MPS

J>re5<1IefJ1-Elect, presenWd reslAS from the"

rt'Spec1I...:!

research

prqects . ...noch coulj be c:ooSIdruKI as bukli1g ~ In the cstab


foSlmenl of I'QRI. I'l <KId;\""" D<. Mwloo <le4io'1catf)d the ,ores that
AAPS IIof l UIOOf\;# for lI. s "' i"~ tNc PQRI is en in itiatNc tor If>c
food and
.IOnnSIrM'on (FDA~ p/larfTl<lCEOJlicaI comPllrlO::s and
lMlMm;,lJcs 10 joo:1 togetheIlo prWOO OPlXlfnnlJeS to ();)I1(Iuct sci

Dr,.

enIJft mselW"l1 proje\:lS (k,'S@e(! 10 r""' nt~'\ proWC! (jUaI ity m..,,'4:
drug devollop"!.'111 and Mli)alion, ,I,bou1 .140 'c..-esenI.Ptives from
FO.t.. ac:adcmoa and ,nc1Jstry pao-tJcJp1(e(I In !he meeIIr(. The ' .goF<lU$ (kswssions and Sl@eS~Offi !Jot the p.atltiP1Y'ts resulCd nine
I(;fr!1(liu1l0n of ~~a \X:jCctrCS if1\1rcs.eam .. Ojects l or POR I
PQRI prc!(x:ts ...1be pet'forn...'tlln aWcr~ 01 COInir(
~ ... the speafoc.JlJDr1ll!Q<.O' cmen\lI 11 testiI'C pUle...
d\lCS to< Ilf(I(klct qua'il)t. ~ is 1'I<l(le(i (hal the li1armao:ewca1 ilOOfr
tly I'M b<-.;)fit IrO'll SOlllO cIliw\:C In the 'eguiiltory proooss in 11K!
form 01 .tIOI'lero~ lite aug awilC81ion prDCeSS IlOO" focilit8l1ll! !he
3f11l1OWi process MIfIi1 FI)I.. Some 01 the p-(Ij(lets bef1i consi<le<ed
'.,.I.,to areas of drug SObst......... , glUC: prO<1Jcts, biopI>iJmH""lII>cs
and sdero::e mlr1 ageort'rlt , ~ is 1Il1ltip.al;:ed thai the research projeds OOl.id be I\Jnded by grants from 1i1;Y~ cornp/!I1"" 0/
01Il(!f SOU!CeS. Two Iihllfl\'\b:)!:utio:;aI ooo'~Oes h<Ne pledged filllJ:\
Cl~ 1 i uP;lCt\ for tile f.()l,ti'lk1l:k:<1 011M l"\\ects ,
MJ'S is ..ork", LO coI~dl.1>O WIth fD/\ to !onnaIim m m<lIlage PQRI.lhe roles lot MPS Illhis ioitoMM!l irdOOc: pnMdire sci-

en~ro:; eXll'lf ~se

ald ~

(T<~""VmQ<hlH;.1 rd",,,,, .. blet".... ' ..,,''''' .mu-....tiJ


d""",~.., f"nLl<
jL"L'c" ' cc" l, such., "" I.j",,,",i""1",,;"k, "", I ""1"""'0"'). Al l ,u~h"" l>or'

,,,J

(",""cd "';,,/! 'he tl"w-.hrouj:h mcduwl for


"-"",,,,rch. ,b"~~x,,,,'" :IIId 'I~"''') ".Ll" ~ 1 \LJ'1 ' '''-~

:H'e,,( in'""", . Co nc".! 1' '' ''c''(i ~'''''.'' i" ", ,h" ~ll.l

,r"",ti<MtI,,,,IiI)l'.'~'" ....1 ''''~bti<M' ,of the 101 1>rOC'edu", il",lf " ,II ~I>" he (\H,,,,kmlfur d", .w:lnl

'''''.I

The S<.,; "",ifi~ " ""It<


I", ",,,,,,,,,",1 ", lh,'
f, " ", "f I~LI,I"',,'ion, ' If ,1,>C\or.I,lLc""" "I""h ".'"
I'"L,J"I",I ()t" """"1",=(,,<1 ,Iunng 'he lo<, j )''''''''"
Xicntit", ""Mor ""hni'''' (I(""""~"L' .< I."kll. :
"" ", 10 S( )'I i\''\ AC loy Scp"'''''O<T J(), J'N~,
11,e l"l><"rs " ,ill he I,"~I I~'~" intcm.,;u",rI
<:O~lllnnt~ 1"..1,,,1 L) p",r. U r. (I. .\";I k, .,,,1,1,,,
fnll" "'ing pri,","", willI ", """nlc~l:

I <I Pri..,
} '" I ,. m.e
Jrd 1'",<

rocutral """'(Olrnen:: p!(Md~ ~o;ltaIiI(!

IlI1CtKms fo' "ORI: c1spcrs l1g PQR I fW"lds: orgarw,i'll AAPS WO<1!.
shops to discuss 'MIlliS oIlhc research p!OjeclS in! a:Ol\Ie)'i'lg
!he ,erulLng A)COm!lll!l1daions to RlA: ald. !XI(lI"d!oOO,. PQR~relal

Kdc"''''"e',.

l'~P ,1i""~L"" '" Ie" 110

'""<I'"

II... " ~cr. Ag". ' "", "f' he SO ,,,"eLL '

11",. i,u,1 ,," Ii,,,, tuhu i'lue.

1. I).

Ili" " il\gc>lc 11)('


CI r ~ I H ,\J""h ..'iIlSw"~.crb",1

l' l, un" H(oI!.j~ i H 54


F,. O(,jM~ 1 IJ II
EnULI s,,, .. ij,,,,,,,,,,,,,',,u:.a~,,

\\'

'\I'I ,""lu, I'SP- "" "","ir~


n"'"L<. J. I'b,.,.", . . 6 1( 10) :
1 6,l ~ 1(40{1'!i1),

v,.

3. \\ . J..~","h , I'......
Ilc"",""c. I). '\1. IIo .. r"y un,1 \.
t< . l.~". A '<JflLI "' ''' 'j,'c """ )' "f

~ , .\. J I l\c"le" 3nd C. S.


" ,,"'. Iml'n.>,",~II ldrool)"''''n
i,... to,. (j'1' \1'1"""u,!, IJii!du
fl OII 'hdJ/lol".~i<1 , 3(2) .\ hy

Ill' .nd l'.I,J ",..,in)\ h.<lo, ,Ii".

1'.1'/6.

."It";",,
"1'1"'""""']' I'b",."..
I'b",.",.-.I, H: I !+, 11.1 (I
'~ I) ,

(I'n!) ,

c: n ... c. 1', Wd l"

If,..,,,,

of ,b
in ,~I ""' ..... 'n'"
f,," n th>! or . 'phe", , ]. !'bum'
..../ 71(4): N.' -W) (I'J~21

+. ,\1. 1/."",l i",J, 1/., C" ",,, I!.

At ,,;::\( )\ I'u~n(, -\ I ENTS

We gra,d,tll )'

.dnn,,' le.jj:~

.[ S. ',....1' .",1A.

J. E 1:1.",,1. E -\. R~,"';"" .,,,').

V.n t-..d In,lus,n"," r. .. ,he ,kM'"

t: " LI\~. S~"'e",,,ie em,r:mo~iol ..~1 "'i( h '\1'1 "' '''''''' 1 "I' ,I",

n. S,h"or'L. "orioti,,,, < ",

I,,,,,

Il.

FI"t"~,,,

,h " ol " ,i""

d"l "

"" "l{

on

fra,,,,,,

1000 Swio;< Ir. """

,.o."".fd J''''' rrt,"", ,.,~,

" M,,'I f)im rlUllim '''rhH'''UII:!.


\1.> ....,,1 Dekk",. I".,. "y (I'NI)
rl' 'Ii. R. J. I\'irh~"y ~, ..I A. J

H ,t~IHI

)000 \" M

l(W~1 SW I ~' rr""~.,

So-I;\.\: .\G II,\SE!.

ed tranirt.
Other p.artO:Lpatir\t orgm Liatioos 10 PQRl lo:::We PharrnoccutrCIII
Res(oan;h ana Manu1ar::turetS 01 America (1'IlRMA). Generic Pharma
ceu\ocaIlnr:lUstry J.swQat..... (G'IA). Natrona! A,S!;ocial(/O 01 Ph3r
maceUliCIII ~Ioctu rcrs (N.O.PM). P... emert, 1Drug Associa!ion
II'DAJ. Nooprosc'f(Oon Drug Manul1ICturers AsSOC;atLOo(NDMA.)
and Natrona! PhaornacEUtk;:al AtliM(:e (t.l'lI.j.

REfERENCES

,nll"'",,,,'1' ill

I')L"II! ,Old ,,, tlcor k 'h" ,)(.~"si<M'. " h:t! ,h;,]eol,o ><.1
"I' on ."...... ~ ... ..,;.,,,,,,,. ;n ,I", r",kl ofbr'1,luml:l'
""u,i,",. '111~ ,,,,,, ,,1 willi", din...;,,,1
ric,,..
' ''''' w l ~' "r" i""o l,,,1 in ll"',",,",,'~"ti.,,,, L ~ '''~ Ih.
Il,,,. - ,hrou~h 'rSlm~ The 5l;"n"oc _I n;duucli
,,,,,.,."~':l(i' ~, u"y he prc"OU''''''LfI) r,,,,,,,,",1 un
,,,,di,,, m "<.",,,i,,<[ di ffer"nL'ypes "I' H"" 11"'"'1"'
""lis .oJ J."",~'C funn< (e.n. ''''''IC.n.'e .",1 n>n-

"r Ih~

,t,,,d, ,,1 l " ",1

1',.". ,h", luli"" " o.~ I"

You might also like